L LUSIS
LIVE

Serial Number

98458857

Owner

Sansureus, Inc.

Attorney

Steven K. Lee

Filing Date

Mar 20, 2024

Add to watchlist:

No watchlists yet
View on USPTO

L LUSIS Trademark

Serial Number: 98458857

L LUSIS is a trademark filed by Sansureus, Inc. on March 20, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Sansureus, Inc. (14 trademarks)

1900 Proforma Ave.
Ontario, CA 91761

Entity Type: 03

LUSIS BIOSCIENCES, INC. (14 trademarks)

3500 BREAKWATER COURT
HAYWARD, CA 94545

Entity Type: 03

Trademark Details

Filing Date

March 20, 2024

Registration Date

Not Registered

Published for Opposition

November 5, 2024

Goods & Services

Injectable pharmaceuticals for treatment of anaphylactic reactions; Chemical reagents for medical purposes; Antibiotic tablets; Allergy tablets; Medicated water for the treatment of illnesses attributed to insufficient cellular energy; Medicated water for the treatment of allergies, cough, cold, flu, headache, pain; Medicated water for the treatment of infectious diseases, skin diseases and conditions, and internal diseases and conditions; Medicated water for the treatment of pain, nausea and muscle spasms; Medicated water-based solutions for treating skin infections and skin conditions; Medicated water for the treatment of gastrointestinal disorders; Antibiotic ointments; Anti-inflammatory ointments; Medicated ointments for treating dermatological conditions; Purified biochemical medical diagnostic reagents, namely, protein arrays, enzymes, and fluorescent dyes; Biochemical drugs for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; Diagnostic preparations for medical purposes; Chemico-pharmaceutical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory system; Chemical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory systems; Chemical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory system; Chemical reagents for medical or veterinary purposes

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 17, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jun 16, 2026 EX3G
SOU EXTENSION 3 FILED
Jun 16, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 16, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 17, 2025 EXRA
SOU EXTENSION 2 GRANTED
Dec 16, 2025 EX2G
SOU EXTENSION 2 FILED
Dec 16, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 16, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 18, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jun 18, 2025 EX1G
SOU EXTENSION 1 FILED
Jun 17, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 17, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 17, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 5, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 5, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 16, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 28, 2024 CNSA
ASSIGNED TO EXAMINER
Sep 27, 2024 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 11, 2024 ASGN
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 15, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 14, 2024 NWOS
NEW APPLICATION ENTERED
Mar 20, 2024 NWAP